These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 5124364)

  • 1. [Icterus and rifampicin].
    Piéron R; Marien C; Kaufmann JP; Jageux M; Botero M
    Ann Med Interne (Paris); 1971; 122(8):889-96. PubMed ID: 5124364
    [No Abstract]   [Full Text] [Related]  

  • 2. [Rifampicin and icterus. Cases in humans].
    Graisely B; Emery JP; Hugues FC; Marche J
    Therapie; 1971; 26(4):655-69. PubMed ID: 5119120
    [No Abstract]   [Full Text] [Related]  

  • 3. [A case of icterus in the course of treatment with rifampicin. Histological records].
    Laroche C; Caquet R; Desche-Labarthe S; Fraisse B; Lemaigre G
    Ann Med Interne (Paris); 1971 Nov; 122(11):1119-22. PubMed ID: 5150312
    [No Abstract]   [Full Text] [Related]  

  • 4. [Liver tolerance of antitubercular treatment including rifampicin. Study on 214 cases].
    Decroix G; Pujet JC
    Sem Hop; 1973 Jun; 49(30):2219-24. PubMed ID: 4354303
    [No Abstract]   [Full Text] [Related]  

  • 5. [Tuberculosis and jaundice. Study of 103 cases].
    Pilheu JA; De Salvo MC; Barcat JA; Koch OR
    Medicina (B Aires); 1987; 47(1):13-9. PubMed ID: 3613966
    [No Abstract]   [Full Text] [Related]  

  • 6. Rifampicin/pyrazinamide therapy should not be used for latent tuberculosis infection.
    Garca-Doval I
    J Am Acad Dermatol; 2004 May; 50(5):801; author reply 801-2. PubMed ID: 15097974
    [No Abstract]   [Full Text] [Related]  

  • 7. [Jaundice and rifampicin].
    Piéron R; Marien C; Jagueux M
    Sem Hop; 1971 Apr; 47(20):1286-95. PubMed ID: 4326532
    [No Abstract]   [Full Text] [Related]  

  • 8. Safety of the rifampin and pyrazinamide short-course regimen for treating latent tuberculosis infection.
    Ijaz K; McElroy PD; Jereb J; Navin TR; Castro KG
    Clin Infect Dis; 2007 Feb; 44(3):464-5; author reply 465. PubMed ID: 17205462
    [No Abstract]   [Full Text] [Related]  

  • 9. [Icterus caused by rifampicin and isoniazide].
    Haber I; Hubens H; Buyssens N
    Tijdschr Gastroenterol; 1974; 17(3):165-76. PubMed ID: 4454055
    [No Abstract]   [Full Text] [Related]  

  • 10. [Epidemiology of jaundice in phthisiology department: responsibility of rifampicin].
    Oury M; Tuchais E; Tuchais M
    Rev Tuberc Pneumol (Paris); 1970; 34(3):415-22. PubMed ID: 5510436
    [No Abstract]   [Full Text] [Related]  

  • 11. [Classification of liver incidents occurring during antitubercular treatments which include rifampicin].
    Blanchon P; Paillas J; Groseille Y; Holler A; Blanchon F
    Ann Med Interne (Paris); 1974 Dec; 125(12):919-22. PubMed ID: 4469954
    [No Abstract]   [Full Text] [Related]  

  • 12. [The influence of therapeutical and biological parameters on the appearance of side effects and complaints during intermittent chemotherapy of pulmonary tuberculosis (author's transl)].
    Eule H; Iwainsky H
    Prax Klin Pneumol; 1981 Aug; 35(8):347-53. PubMed ID: 7345430
    [No Abstract]   [Full Text] [Related]  

  • 13. Jaundice due to anti-tuberculous drugs--a dose related phenomenon.
    Mirchandani LV; Joshi JM
    J Assoc Physicians India; 1995 Nov; 43(11):767-9. PubMed ID: 8773037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tuberculosis in the elderly: treating the "white plague".
    Iseman MD
    Geriatrics; 1980 Mar; 35(3):90-107. PubMed ID: 7353794
    [No Abstract]   [Full Text] [Related]  

  • 15. Adverse drug reactions and outcome of elderly patients on antituberculosis chemotherapy with and without rifampicin.
    Chan CH; Or KK; Cheung W; Woo J
    J Med; 1995; 26(1-2):43-52. PubMed ID: 7561530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A retrospective evaluation of completion rates, total cost, and adverse effects for treatment of latent tuberculosis infection in a public health clinic in central massachusetts.
    Young H; Wessolossky M; Ellis J; Kaminski M; Daly JS
    Clin Infect Dis; 2009 Aug; 49(3):424-7. PubMed ID: 19548835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Acute renal insufficiency and interstitial nephritis caused by rifampicin. A comment on this subject].
    Santacruz PL; Agüero F; León ME; Córdoba Z
    Nefrologia; 2001; 21(3):323. PubMed ID: 11471316
    [No Abstract]   [Full Text] [Related]  

  • 18. [Study of hepatic function in patients treated with rifampicin].
    Morère P; Bourreille J; Matray F; Stain JP; Métayer P
    Rev Tuberc Pneumol (Paris); 1970; 34(3):403-14. PubMed ID: 5510435
    [No Abstract]   [Full Text] [Related]  

  • 19. Jaundice after rifampicin.
    Lees AW; Asgher B; Hashem MA; Sinha BN
    Br J Dis Chest; 1970 Apr; 64(2):90-5. PubMed ID: 5432630
    [No Abstract]   [Full Text] [Related]  

  • 20. [Treatment of advanced and complicated variants of osteoarticular tuberculosis with rifampin and ethambutol].
    Suleĭmanov I; Prosvirova LA; Umarov B; Beliakova NK
    Probl Tuberk; 1981 Dec; (12):49-52. PubMed ID: 7335634
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.